These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28521472)

  • 1. CD117 expression is a predictive marker for poor prognosis in patients with non-small cell lung cancer.
    Sakabe T; Azumi J; Haruki T; Umekita Y; Nakamura H; Shiota G
    Oncol Lett; 2017 May; 13(5):3703-3708. PubMed ID: 28521472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Prognostic Significance of CD117 in Non-Small Cell Lung Cancer: A Systemic Meta-Analysis.
    Su Y; Chen R; Han Z; Xu R; Ma L; Wufuli R; Liu H; Wang F; Ma L; Chen R; Liu J
    Pathobiology; 2021; 88(4):267-276. PubMed ID: 34107476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Significance of KIAA1522 Expression in Non-Small-Cell Lung Cancer Patients.
    Özdede M; Taban H; Akman O; Önder S; Kılıçkap S
    Cureus; 2023 Aug; 15(8):e44016. PubMed ID: 37746394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer.
    Herpel E; Jensen K; Muley T; Warth A; Schnabel PA; Meister M; Herth FJ; Dienemann H; Thomas M; Gottschling S
    Anticancer Res; 2011 Dec; 31(12):4491-500. PubMed ID: 22199321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD117 expression is correlated with poor survival of patients and progression of lung carcinoma:a meta-analysis with a panel of 2645 patients.
    Guo YN; Liang L; Ren S; Wu M; Shi DC; Mo WJ; Chen G
    Pol J Pathol; 2019; 70(2):63-78. PubMed ID: 31556556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
    Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
    Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testes-specific protease 50 as an independent risk factor for poor prognosis in patients with non-small cell lung cancer.
    Qiao WL; Shi BW; Han YD; Tang HM; Lin J; Hu HY; Lin Q
    Oncol Lett; 2018 Jun; 15(6):8796-8804. PubMed ID: 29805619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential use of microRNA-200c as a prognostic marker in non-small cell lung cancer.
    Si L; Tian H; Yue W; Li L; Li S; Gao C; Qi L
    Oncol Lett; 2017 Oct; 14(4):4325-4330. PubMed ID: 28943946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer.
    Lu J; Zang H; Zheng H; Zhan Y; Yang Y; Zhang Y; Liu S; Feng J; Wen Q; Long M; Fan S
    PLoS One; 2020; 15(2):e0227768. PubMed ID: 32023262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
    Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
    Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
    Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
    Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
    Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
    Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of filamin-A protein is associated with aggressive phenotype and poor survival outcomes in NSCLC patients treated with platinum-based combination chemotherapy.
    Gachechiladze M; Skarda J; Janikova M; Mgebrishvili G; Kharaishvili G; Kolek V; Grygarkova I; Klein J; Poprachova A; Arabuli M; Kolar Z
    Neoplasma; 2016; 63(2):274-81. PubMed ID: 26774150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tazarotene-induced gene 2 is associated with poor survival in non-small cell lung cancer.
    Cai Q; Huang Z; Qi L; Wang T; Shen Y; Huang J
    Oncol Lett; 2016 Oct; 12(4):2680-2685. PubMed ID: 27698842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.